Vaccines
News
Long COVID–induced activity limitations persist
The prevalence of long COVID in the United States has remained stable, as has the proportion of patients reporting significantly reduced function...
News
CDC offers guidance on RSV vaccines for adults
Rather than targeting all adults 60 and over, the decision calls for consideration of a patients’ risk for disease and their characteristics,...
Conference Coverage
Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
EULAR 2023 served up a bevy of studies on the protection and safety of COVID vaccines for patients and pregnant and breastfeeding women, as well...
News
COVID vaccines safe for young children, study finds
“These results can provide reassurance to clinicians, parents, and policymakers alike.”
Opinion
The new vaccine your patients may not want
How can we incorporate the new RSV vaccine for older adults into our practices and overcome patient hesitancy to receive yet another vaccine?
News
Study of hospitalizations in Canada quantifies benefit of COVID-19 vaccine to reduce death, ICU admissions
Unvaccinated patients were found to be up to 15 times more likely to die from COVID-19 than fully vaccinated patients.
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
News from the FDA/CDC
CDC backs FDA’s call for second COVID booster for those at high risk
The agency is following the recommendations made by its Advisory Committee on Immunization Practices (ACIP).
News
Cancer, heart disease vaccines may be ready by 2030, Moderna says
The announcement is yet another sign of what many are calling “the golden age” of vaccine development.